Mid-Market Commentary

DSIJ Intelligence / 13 Oct 2016

Mid-Market Commentary

The Indian markets saw a deep cut, largely anticipating the Fed to raise interest rates. The Nifty is seen trading near crucial support levels, currently down by 146 points at 8561. The Sensex is 459 points lower at 27625. The indices are trading negative between -1.68 to -1.73 per cent

The Indian markets saw a deep cut, largely anticipating the Fed to raise interest rates. The Nifty is seen trading near crucial support levels, currently down by 146 points at 8561. The Sensex is 459 points lower at 27625. The indices are trading negative between -1.68 to -1.73 per cent

The advance-decline ratio is negative. On the NSE, 717 shares are in the green and 2019 shares are in red.

OCL India: Shiva Cement is in talks with OCL India to sell its inaugurated cement plant in Orissa.

Dr Reddy's Laboratories: Dr Reddy's Laboratories announces the launch of Aripiprazole tablets, USP tablets in the U.S. Market.

Jubilant Life Sciences: Jubilant Life Sciences received ANDA approval for Darifenacin ER Tablets.

Granules India: US FDA has approved Abbreviated New Drug Applications (ANDA) for Ibuprofen Tablets USP, 200 mg (OTC) filed by Granules India.

Inox Wind: Inox Wind bags repeat order from Malpani Group for 40MW.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.